)
)
Allakos Investor Relations Material
Latest events
Study Result
Allakos
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Allakos Inc
Access all reports
Allakos Inc. is a biopharmaceutical company focused on the development of antibody-based therapies for the treatment of allergic, inflammatory, and proliferative diseases. The company's primary approach involves targeting specific immune cells and inflammatory pathways that contribute to diseases such as eosinophilic gastritis and other related gastrointestinal and inflammatory conditions. Allakos leverages proprietary antibody technologies to create potential therapeutic options aimed at improving outcomes for patients with limited treatment choices. The company is headquartered in San Carlos, California, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ALLK
Country
🇺🇸 United States